(Q31876946)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11165136%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

title

Ecteinascidin-743 (ET-743), a natural marine compound, with a unique mechanism of action (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11165136%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11165136%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

Maurizio D'Incalci

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11165136%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

author name string

E Erba

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11165136%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

L Bassano

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11165136%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

G Damia

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11165136%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

S Ronzoni

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11165136%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

G T Faircloth

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11165136%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

publication date

1 January 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11165136%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Cancer

3 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11165136%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

volume

37

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11165136%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11165136%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

page(s)

97-105

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11165136%20AND%20SRC:MED&resulttype=core&format=json

Ecteinascidins 729, 743, 745, 759A, 759B, and 770: potent antitumor agents from the Caribbean tunicate Ecteinascidia turbinata

3 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900357-9

7 January 2021

In vitro schedule-dependency of myelotoxicity and cytotoxicity of Ecteinascidin 743 (ET-743).

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900357-9

7 January 2021

In vitro antitumor activity of the novel marine agent, ecteinascidin-743 (ET-743, NSC-648766) against human tumors explanted from patients

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900357-9

7 January 2021

Ecteinascidin 743: a minor groove alkylator that bends DNA toward the major groove

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900357-9

7 January 2021

DNA sequence- and structure-selective alkylation of guanine N2 in the DNA minor groove by ecteinascidin 743, a potent antitumor compound from the Caribbean tunicate Ecteinascidia turbinata

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900357-9

7 January 2021

Characterisation of antimitotic products from marine organisms that disorganise the microtubule network: ecteinascidin 743, isohomohalichondrin-B and LL-15.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900357-9

7 January 2021

Poisoning of human DNA topoisomerase I by ecteinascidin 743, an anticancer drug that selectively alkylates DNA in the minor groove

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900357-9

7 January 2021

Recent progress with the DNA repair mutants of Chinese hamster ovary cells

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900357-9

7 January 2021

Comparison of cell-cycle phase perturbations induced by the DNA-minor-groove alkylator tallimustine and by melphalan in the SW626 cell line

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900357-9

7 January 2021

Characterization of cyclin B1 expression in human cancer cell lines by a new three-parameter BrdUrd/cyclin B1/DNA analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900357-9

7 January 2021

Phthalascidin, a synthetic antitumor agent with potency and mode of action comparable to ecteinascidin 743.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900357-9

7 January 2021

Sensitivity of CHO mutant cell lines with specific defects in nucleotide excision repair to different anti-cancer agents.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900357-9

7 January 2021

Determination of the structural features of (+)-CC-1065 that are responsible for bending and winding of DNA

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900357-9

7 January 2021

DNA sequence-specific adenine alkylation by the novel antitumor drug tallimustine (FCE 24517), a benzoyl nitrogen mustard derivative of distamycin

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900357-9

7 January 2021

The major adduct of the antitumor drug cis-diamminedichloroplatinum(II) with DNA bends the duplex by approximately equal to 40 degrees toward the major groove

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900357-9

7 January 2021

Interference of transcriptional activation by the antineoplastic drug ecteinascidin-743.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900357-9

7 January 2021

Ecteinascidin 743, a transcription-targeted chemotherapeutic that inhibits MDR1 activation

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900357-9

7 January 2021

Cisplatin and adriamycin resistance are associated with MutLalpha and mismatch repair deficiency in an ovarian tumor cell line

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900357-9

7 January 2021